Sumaiah J Alarfaj
Overview
Explore the profile of Sumaiah J Alarfaj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alarfaj S, El-Haggar S, Hegazy S, Maher M, Bahgat M, Elmasry T, et al.
Front Med (Lausanne)
. 2025 Feb;
11:1490178.
PMID: 39911672
Background: Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon. Several preclinical studies investigated the beneficial effects of atorvastatin in colitis. Activation of sphingosine 1 phosphate (S1P)/ tumor...
2.
Alarfaj S, Alsulami S, Alashjaey E, Albulayhi R, Alqarni F, Alharbi A
Saudi Med J
. 2024 Dec;
45(12):1374-1382.
PMID: 39658120
Objectives: To compare the effectiveness of providing telepharmacy anticoagulation to on-site clinics in achieving optimal outcomes for patients newly starting warfarin. Methods: This single-center retrospective cohort study included adult patients...
3.
Alarfaj S, Bahaa M, Elmasry T, Elberri E, El-Khateeb E, Hamouda A, et al.
Drug Des Devel Ther
. 2024 Nov;
18:5239-5253.
PMID: 39575188
Background: Ulcerative colitis (UC) is an idiopathic chronic inflammation of colonic and rectal mucosa. The peroxisome proliferator-activated receptor α (PPARα) has been identified as having protective effects in UC. Aim:...
4.
Alenzi S, Alzahrani A, Aljaloud A, Alanazi K, Alarfaj S
Front Endocrinol (Lausanne)
. 2024 Aug;
15:1395651.
PMID: 39205685
Background: Semaglutide is a glucagon-like peptide-1 receptor agonists (GLP-1-RAs) approved for the treatment of type 2 diabetes mellitus (T2DM) at doses up to 1 mg. The results from randomized control...
5.
Abdel-Salam Elgohary M, Ali A, Alarfaj S, Shahin H, Ibrahim Zaki A, Medhat Hasan E, et al.
Cytokine
. 2023 Nov;
173:156433.
PMID: 37972479
Severe COVID-19 pneumonia is a principal cause of death due to cascade of hyper inflammatory condition that leading to lung damage. Therefore, an effective therapy to countercurrent the surge of...
6.
Al Sulaiman K, Korayem G, Aljuhani O, Altebainawi A, Shawaqfeh M, Alarfaj S, et al.
Front Med (Lausanne)
. 2023 Sep;
10:1237903.
PMID: 37692775
Background: Despite insufficient evidence, vitamin D has been used as adjunctive therapy in critically ill patients with COVID-19. This study evaluates the effectiveness and safety of vitamin D as an...
7.
Alarfaj S, Mostafa S, Negm W, El-Masry T, Kamal M, Elsaeed M, et al.
Pharmaceuticals (Basel)
. 2023 Jun;
16(2).
PMID: 37259466
Individual differences in IBD illness severity, behavior, progression, and therapy response are evident. Since a break in the intestinal epithelial barrier causes IBD to begin, mucosal gene expression in IBD...
8.
Al-Kuraishy H, Al-Gareeb A, Alarfaj S, Khalifah Al-Akeel R, Faidah H, El-Bouseary M, et al.
Sci Rep
. 2023 Apr;
13(1):5977.
PMID: 37045862
Patients with coronavirus disease 2019 (COVID-19) were shown to have reduced serum testosterone levels compared to healthy individuals. Low testosterone levels are linked with the development of erectile dysfunction (ED)....
9.
Alarfaj S, Alzahrani A, Alotaibi A, Almutairi M, Hakami M, Alhomaid N, et al.
Saudi Pharm J
. 2022 Nov;
30(10):1448-1453.
PMID: 36387341
Background: The introduction of direct-acting antivirals (DAA) to treat the hepatitis C virus (HCV) overcame many drawbacks of interferon-based therapy. DAA achieved sustained viral response (SVR) rates above 90% and...
10.
Alarfaj S, Mostafa S, Abdelsalam R, Negm W, El-Masry T, Hussein I, et al.
Front Med (Lausanne)
. 2022 Jul;
9:902255.
PMID: 35801205
The relationship between () infection and Portal hypertensive gastropathy (PHG) is still a debatable matter. The aim of this study is to find out how common infection is in cirrhotic...